Bill Anderson to become new CEO of Bayer

Bill Anderson will become new Chief executive officer (CEO) of the German conglomerate Bayer. Anderson will take up the responsibility from April.

Bayer's incumbent CEO Werner Baumann will exit early after serving the company for 35 years. Baumann has been leading the company for seven years and he was supposed to serve as the CEO till April, 2024.

Bill Anderson was Roche's pharmaceutical chief.


Meanwhile, Baumann's impending exit comes amidst criticism from investors. Shareholders have been venting anger against Bayer's incumbent CEO Werner Baumann since the acquisition of Monsanto in 2018.


Anderson's selection was backed by Bayer’s board. The selection process began in mid-2022.

Bayer has praised Anderson's track record as the former Roche executive was involved in development and launches of 25 new medicines.

FAQs:

1. What is Bayer?
   Bayer is a German pharmaceutical and biotechnology company.
2. Is Bayer a German company?
   Bayer is a German multinational company.